N-Nitroso dabigatran Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds .Dabigatran is used to treat deep vein thrombosis (DVT; a blood clot, usually in the leg) and pulmonary embolism (PE; a blood clot in the lung) in adults and children 3 months of age and older who have been treated with an injectable anticoagulant ('blood thinner').N-Nitroso Dabigatran Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Dabigatran Impurity 1 CAS NO: 2892260-29-4 also known as N-Nitroso Dabigatran Etexilate or N-Nitroso dabigatran Impurity & it is chemically represented as ethyl 3-(2-(((4-(N-((hexyloxy)carbonyl)carbamimidoyl)phenyl)(nitroso)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate. Synchemia is the leading manufacturing and exporter of N-Nitroso Dabigatran Impurity 1 .We supply N-Nitroso Dabigatran Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142611 |
| CAS No | NA |
| Mol.F. | C14H18Cl2N2O2 |
| Mol.Wt. | 317.21g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142612 |
| CAS No | NA |
| Mol.F. | C18H27N3O2 |
| Mol.Wt. | 317.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142613 |
| CAS No | NA |
| Mol.F. | C15H21N3O2 |
| Mol.Wt. | 275.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142614 |
| CAS No | NA |
| Mol.F. | C15H20ClN3O2 |
| Mol.Wt. | 309.79 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142615 |
| CAS No | NA |
| Mol.F. | C16H23ClN3O2 |
| Mol.Wt. | 324.83 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142616 |
| CAS No | NA |
| Mol.F. | C18H26BrN3O2 |
| Mol.Wt. | 396.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142617 |
| CAS No | NA |
| Mol.F. | C18H26ClN3O2 |
| Mol.Wt. | 351.88 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142618 |
| CAS No | NA |
| Mol.F. | C18H27N3O2 |
| Mol.Wt. | 317.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142619 |
| CAS No | NA |
| Mol.F. | C16H23N3O2 |
| Mol.Wt. | 289.38 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142620 |
| CAS No | NA |
| Mol.F. | C17H25N3O2 |
| Mol.Wt. | 303.41 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142621 |
| CAS No | NA |
| Mol.F. | C18H27N3O3 |
| Mol.Wt. | 333.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142622 |
| CAS No | NA |
| Mol.F. | C5H7N3O2S |
| Mol.Wt. | 173.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142623 |
| CAS No | NA |
| Mol.F. | C11H9ClN6O2S |
| Mol.Wt. | 324.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142624 |
| CAS No | NA |
| Mol.F. | C11H9ClN6O2S |
| Mol.Wt. | 324.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142625 |
| CAS No | NA |
| Mol.F. | C9H6ClN7O2S |
| Mol.Wt. | 311.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142626 |
| CAS No | NA |
| Mol.F. | C12H15ClN2O3 |
| Mol.Wt. | 270.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |